다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

MRNA

Moderna (MRNA)

Moderna Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:MRNA

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/11/30	05:54	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MRNA	Moderna Inc
2024/11/30	05:49	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MRNA	Moderna Inc
2024/11/30	05:35	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MRNA	Moderna Inc
2024/11/13	06:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNA	Moderna Inc
2024/11/12	23:27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MRNA	Moderna Inc
2024/11/08	21:30	PR Newswire (US)	Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma	NASDAQ:MRNA	Moderna Inc
2024/11/08	06:03	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:MRNA	Moderna Inc
2024/11/07	20:33	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MRNA	Moderna Inc
2024/11/07	20:19	IH Market News	U.S. Futures Rise as Investors Await Fed Rate Decision; Oil Prices Drop	NASDAQ:MRNA	Moderna Inc
2024/11/06	20:09	IH Market News	Trump Media Shares Surge 32% Pre-Market; Tesla Jumps 13%; Coinbase Rises with BTC All-Time High	NASDAQ:MRNA	Moderna Inc
2024/11/05	23:05	PR Newswire (US)	Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024	NASDAQ:MRNA	Moderna Inc
2024/10/28	19:45	Business Wire	Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)	NASDAQ:MRNA	Moderna Inc
2024/10/23	21:00	PR Newswire (US)	Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence	NASDAQ:MRNA	Moderna Inc
2024/10/09	05:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNA	Moderna Inc
2024/10/07	18:45	PR Newswire (US)	Shareholders of Moderna, Inc. Should Contact The Gross Law Firm Before October 8, 2024 to Discuss Your Rights - MRNA	NASDAQ:MRNA	Moderna Inc
2024/10/04	21:52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNA	Moderna Inc
2024/10/04	21:49	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MRNA	Moderna Inc
2024/10/03	21:00	PR Newswire (US)	Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors	NASDAQ:MRNA	Moderna Inc
2024/10/02	20:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MRNA	Moderna Inc
2024/09/30	18:45	PR Newswire (US)	MRNA LAWSUIT ALERT: The Gross Law Firm Notifies Moderna, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline	NASDAQ:MRNA	Moderna Inc
2024/09/26	18:45	PR Newswire (US)	Shareholders that lost money on Moderna, Inc.(MRNA) Urged to Join Class Action - Contact The Gross Law Firm to Learn More	NASDAQ:MRNA	Moderna Inc
2024/09/23	18:45	PR Newswire (US)	Moderna, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before October 8, 2024 to Discuss Your Rights - MRNA	NASDAQ:MRNA	Moderna Inc
2024/09/19	18:45	PR Newswire (US)	The Gross Law Firm Reminds Moderna, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 8, 2024 - MRNA	NASDAQ:MRNA	Moderna Inc
2024/09/16	18:45	PR Newswire (US)	MRNA LAWSUIT ALERT: The Gross Law Firm Notifies Moderna, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline	NASDAQ:MRNA	Moderna Inc
2024/09/13	19:12	IH Market News	OpenAI Unveils Strawberry AI Model Series; Boeing Stock Falls 4% Amid Strike; HR Surges 20% on Growth Forecast	NASDAQ:MRNA	Moderna Inc
2024/09/12	19:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MRNA	Moderna Inc
2024/09/12	18:45	PR Newswire (US)	Moderna, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - MRNA	NASDAQ:MRNA	Moderna Inc
2024/09/11	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNA	Moderna Inc
2024/09/10	20:30	PR Newswire (US)	Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases	NASDAQ:MRNA	Moderna Inc
2024/09/10	04:29	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MRNA	Moderna Inc

검색 관련기사 보기:NASDAQ:MRNA

1 2 3 4 5 6 7 8 9 10 다음 >>

BNP Paribas (QX)

JP Morgan Chase

American Express

US Dollar vs Sterling

Bank of America

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관